ZURA BIO LIMITED Shares Outstanding (Cover Page)
ZURA BIO LIMITED (ZURA) had Shares Outstanding (Cover Page) of 95.83 million shares as of 2026-08-11, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-11: Entity Common Stock, Shares Outstanding 95.83M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 95.00M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 94.88M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 65.02M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-11 | 95.83M shares 10-Q · filed 2026-08-11 | |
| 2026-05-04 | 95.00M shares 10-Q · filed 2026-05-07 | |
| 2026-03-16 | 94.88M shares 10-K · filed 2026-03-19 | |
| 2025-11-10 | 65.02M shares 10-Q · filed 2025-11-13 | |
| 2025-08-04 | 65.02M shares 10-Q · filed 2025-08-14 | |
| 2025-05-05 | 61.87M shares 10-Q · filed 2025-05-08 | |
| 2025-03-21 | 68.37M shares 10-K · filed 2025-03-25 | |
| 2024-11-04 | 65.29M shares 10-Q · filed 2024-11-07 | |
| 2024-05-09 | 63.68M shares 10-Q/A · filed 2024-05-15 | 43.59M shares 10-Q · filed 2024-05-09 |
| 2024-03-26 | 43.59M shares 10-K · filed 2024-03-28 | |
| 2023-11-13 | 43.59M shares 10-Q · filed 2023-11-13 | |
| 2023-08-14 | 43.09M shares 10-Q · filed 2023-08-14 | |
| 2023-05-12 | 27.05M shares 10-Q · filed 2023-05-12 | |
| 2023-03-19 | 5.14M shares 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |